Facelift in France
Facelift in France section, includes general infrmation about Facelift Procedure, Facelift France Local News, Facelift France Surgeon Locator and other Facelift related material.
Facelift Procedure
As we become older the gravity, sun exposure and everyday stress leave their marks on our faces. Wrinkles appear between the nose and the mouse, the skin becomes lose and drop below the jaw line and extra fat and skin accumulates around the neck. Facelift cannot stop the aging process but it can "turn back time" by removing extra skin and fat and straitening the muscles.
The ideal candidates for the procedure are patients with skin of the face and neck that started to drop but still has its elasticity.
The operation last from 3-7 hours (it can be longer if additional procedures are done). Some surgeons prefer to work on each side at a time and some do both sides simultaneously. The placement of the cuts and the magnitude of the operation depend on face structure and the correction required. The cut usually starts on the forehead goes in front of the ear and behind the ear lobe, additional cut below the chin is made to repair the neck. The surgeon separates the skin from the fat, removes the extra fat, strengthens the muscles and returns the fat pockets where they use to be. Afterwards he stretches the skin, cuts the extra and closes with sutures. A drainage tube usually left from both sides to draine secretions and blood and the face is bandaged for the first 24 hours.
Every operation has its risks although not common those include, bleeding, infection, damage to facial nerves (usually temporal), face asymmetry and delayed healing. Patients who smoke have higher rates of delayed healing.
There may be pain or uncomfortable felling after the recovery that can be treated with painkillers. A sensation of ants crawling usually disappears after weeks or a month after the surgery. Bandages are removed after a day or two and your face may look swollen. Red or pale with bleeding spots, you must remember that those will disappear after few days or weeks.
You can get out of bed after 24 hours but you should avoid any efforts for at least a week to help the healing process. You should avoid alcohol, hot tubs and saunas for at least a month. Most of the patients feel disappointed at first, their face look and feel strange but after a few weeks the scars will heal and you'll be able to see the final results. Many patients return to work after 3 weeks. Sometimes you may need to use make up to blur the hemorrhage spots.
Other Facelift Procedures
All Face Procedures
Facelift France (current)
Facelift France BOTOX® Cosmetic
Facelift France Ear Surgery
Facelift France Jaw Surgery
Facelift France Browlift
More France info...
France Overseas territories
French Polynesia (Tahiti)
New Caledonia (Nouvelle Caledonie)
Saint Pierre et Miquelon
Mayotte
Wallis et Futuna The following overseas territories are remote possessions kept as natural reservations:
France Climate A lot of variety, but temperate. Cool winters and mild summers on most of the territory, and especially in Paris. Mild winters and hot summers along the Mediterranean and in the south west( the latter has lots of rain in winter). Mild winters (with lots of rain)and cool summers in the north west (Brittany). Cool to cold winters and hot summer along the German border (Alsace). Along the Rh?ne Valley, occasional strong, cold, dry, north-to-northwesterly wind known as the mistral. Cold winters with lots of snow in the Montainous regions: Alps, Pyrenees, Auvergne
Plastic Surgery News...
- According to PharmaLive, the FDA has approved abatacept (Orencia®) for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in paediatric patients aged six years and above. It may be used as monotherapy or concomitantly with methotrexate (MTX), but should not be used concomitantly with tumour necrosis factor (TNF) antagonists or other biological therapy (e.g. anakinra).
This approval is based on the AWAKEN trial, which included 190 patients aged 6-17 years with moderately to severely active polyarticular JIA who had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). The first part was a 4-month, open-label lead-in phase in which patients received IV abatacept (10 mg/kg; maximum 1,000 mg) on Days 1, 15, 29 and every month thereafter. Those who achieved an ACR Pedi 30 response entered Period B - a six-month, double-blind phase involving randomisation to remain on abatacept (n=60) or to receive placebo (n=62) for six months. The primary endpoint of the study was time to occurrence of disease flare.
The main findings were as follows:
• In the lead-in phase, abatacept treatment resulted in a consistent improvement in ACR Pedi 30 across all JIA subtypes (oligoarticular extended - 59.3%; polyarticular-RF positive - 68.4%; polyarticular-RF negative - 64.3%; and systemic JIA with polyarticular course - 64.9%)
• The time to occurrence of disease flare was statistically significantly longer in patients treated with abatacept compared to patients treated with placebo compared with abatacept (p=0.0002) [no specific details given on magnitude of this difference]
• Patients treated with abatacept experienced fewer disease flares compared to placebo-treated patients (20% versus 53%, respectively, p<0.001)
• The risk of disease flare among patients continuing on abatacept was less than that for patients who withdrew from abatacept treatment (HR 0.31, 95% CI 0.16 to 0.59)
Please see the link above for further details.
- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, announced that the U.S.